✦ LIBER ✦

MicroRNAs in inflammatory bowel disease

✍ Scribed by Joel R. Pekow; John H. Kwon

Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 92 KB
Volume: 18
Category: Article
ISSN: 1078-0998
DOI: 10.1002/ibd.21691

No coin nor oath required. For personal study only.

✦ Synopsis

MicroRNAs (miRNAs) are small, noncoding RNAs that regulate gene and protein expression. miRNAs are critical to a normal immune response and have altered expression in multiple immune-mediated disorders. This emerging role of miRNAs in the pathogenesis of multiple disease states has led to investigations into miRNA expression profiles in inflammatory bowel disease (IBD). The discovery of miRNAs in IBD is likely to contribute to our understanding of IBD pathogenesis and lead to clinical advances in IBD. This review focuses on miRNA expression in inflammation, autoimmune disorders, and inflammation-associated cancer, as well as their function in the biology and management of IBD.

📜 SIMILAR VOLUMES

Differential MicroRNA expression tracks

Differential MicroRNA expression tracks neoplastic progression in inflammatory bowel disease-associated colorectal cancer

✍ Ziad Kanaan; Shesh N. Rai; M. Robert Eichenberger; Christopher Barnes; Amy M. Dw 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 486 KB

## One of the most serious complications faced by patients with inflammatory bowel disease (IBD) is the potential development of colorectal cancer (CRC). There is a compelling need to enhance the accuracy of cancer screening of IBD patients. MicroRNAs (miRNAs) are small nonprotein-coding RNAs that

Dynamic changes in the expression of Mic

Dynamic changes in the expression of MicroRNA-31 during inflammatory bowel disease-associated neoplastic transformation

✍ Alexandru V. Olaru; Florin M. Selaru; Yuriko Mori; Christine Vazquez; Stefan Dav 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 490 KB

Background: Patients with inflammatory bowel disease (IBD) are at increased risk of developing colorectal cancer. Aberrant microRNA (miR) expression has been linked to carcinogenesis; however, no reports document a relationship between IBD-related neoplasia (IBDN) and altered miR expression. In the

Lymphoma in inflammatory bowel disease

✍ Adrian J. Greenstein; Gerard E. Mullin; James A. Strauchen; Tomas Heimann; Henry 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 481 KB 👁 1 views

Antimicrobial cover in inflammatory bowe

Antimicrobial cover in inflammatory bowel disease

✍ R. V. Fiddian; M. R. B. Keighley 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 127 KB 👁 2 views

Pyoderma gangrenosum in inflammatory bow

Pyoderma gangrenosum in inflammatory bowel disease

✍ M. D. Levitt; J. K. Ritchie; J. E. Lennard-Jones; Mr. R. K. S. Phillips 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 293 KB 👁 2 views

Mucocutaneous manifestations in inflamma

Mucocutaneous manifestations in inflammatory bowel disease

✍ İlhami Yüksel; Ömer Başar; Hilmi Ataseven; İbrahim Ertuğrul; Mehmet Arhan; Mehme 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB 👁 1 views

## Background: The aim of this study was to evaluate the prevalence and features of the major cutaneous manifestations (erythema nodosum [en] and pyoderma gangrenosum [pg]) and to determine the associations between cutaneous manifestations and other extraintestinal manifestations in patients with i